Jury Rules Medtronic Violated Patent, Awards $392.5 Million

January 15, 2014


WILMINGTON, DE – In this patent infringement case, a federal jury determined that Medtronics, Inc. willfully infringed on Edwards Lifescience’s trans-catheter heart valve patent and issued a verdict that will cost the medical device maker more than $392 million.


Partners Nicholas Groombridge and Catherine Nyarady (Paul, Weiss, Rifkind) represented Edwards Lifesciences in the courtroom. Impact’s team of Thomas S.Y. Lee, Joel DePalma, John Christopher, Alison Von Dollen and Jeff Woodbury worked closely with the trial team to provide invaluable trial technology and litigation graphics consulting and support.


Edwards Lifesciences LLC, et al. v. Medtronics Corevalve LLC, et al., 1:12-CV-00023, US District Court – District of Delaware.